共 250 条
[11]
Miyakoshi S(2014)Busulfan triggers epileptic seizures under levetiracetam and valproic acid therapy Pediatr Transplant 18 412-413
[12]
Usui N(2006)Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects Clin Ther 28 734-744
[13]
Yano S(2017)Levetiracetam clinical pharmacokinetic monitoring in pediatric patients with epilepsy Clin Pharmacokinet 56 1267-1285
[14]
Kawano Y(2003)Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials Epilepsy Res 53 47-56
[15]
Nagatoshi Y(1993)Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 118 255-267
[16]
Harada M(2016)Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation Int J Hematol 104 644-646
[17]
Morishima Y(1991)High dose busulfan and seizures Bone Marrow Transplant 7 363-364
[18]
Okamoto S(2014)Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation Biol Blood Marrow Transplant 20 282-285
[19]
Saito AM(2002)Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study Biol Blood Marrow Transplant 8 145-154
[20]
Ohashi Y(2009)Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial Lancet oncol 10 115-124